About US
Contact us
-
United Therapeutics reaches $1.2bn licensing deal with ArenaBiotechnology company United Therapeutics has signed a licensing deal worth up to $1.2bn with biopharmaceutical firm Arena Pharmaceuticals for a hypertension drug candidate, ralinepag. Ralinepag is A2018/11/19
-
M&As this week: Nestle Health, InvaGen, TakedaNestle Healthhas acquired a 19% stake in Aimmune Therapeutics for $98m. The companies have also extended a prior agreement for developing food allergy treatments by two years. The agreement allows Ai2018/11/19
-
FDA agrees to review Roche’s Tecentriq combination for breast cancerThe US Food and Drug Administration (FDA) has accorded priority review status to the supplemental biologics licence application (sBLA) of Roche’s Tecentriq (atezolizumab) as a combination therapy for2018/11/16
-
Pfizer loses Lyrica patent case in UK Supreme CourtThe UK Supreme Court has ruled against Pfizer in a long running legal case involving a second medical use patent for its Lyrica (pregabalin) drug. Lyrica was initially developed for the treatment of2018/11/16
-
InvaGen to acquire Avenue Therapeutics for $215mInvaGen Pharmaceuticals, a unit of India-based Cipla, has signed definitive agreements to buy US-based specialty pharmaceutical firm Avenue Therapeutics for a total consideration of $215m. Avenue The2018/11/15
-
Sobi to buy US rights to AstraZeneca’s Synagis drug for $1.5bnSwedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) has signed agreements to acquire the rights to AstraZeneca’s Synagis (palivizumab) medicine in the US for an upfront payment of $1.5bn.2018/11/15
-
Nestle Health increases stake in Aimmune TherapeuticsNestlé Health Science has raised its equity stake in biopharmaceutical firm Aimmune Therapeutics to around 19% with an investment of $98m. The deal increases Nestle Health’s total investment in Aimmu2018/11/14
-
WHO finds wide differences in global antibiotics consumptionA survey by the World Health Organization (WHO) has revealed huge variations in the use of antibiotics across the world, with certain countries recording very high levels of consumption. The WHO Repo2018/11/14
-
Asterias Biotherapeutics to merge with BioTimeUS-based biotechnology firms BioTime and Asterias Biotherapeutics have entered into a definitive merger agreement to form an integrated company focussed on cell therapies. Under the terms o2018/11/13
-
Takeda sets date for shareholder EGM over acquisition of ShireJapan-based pharmaceutical company Takeda has announced 5 December as the date of its emergency general meeting (EGM) where shareholders will vote on its acquisition of UK-listed Shire for $62bn. If2018/11/13